{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Podcast #297: Truvada","description":"Educational Pearls  Truvada (Emtricitabine\/tenofovir) is a combination nucleotide reverse transcriptase inhibitor that can be used as pre-exposure prophylaxis (PrEP) for HIV. It has been shown to dramatically reduce the risk of contracting HIV. It is used in high-risk patients, like the MSM community or those who are in a relationship with someone with HIV. Side effects include nausea, vomiting, headache, and liver damage. HIV testing should be performed every 3 months while taking it, since it is not meant to fight an actual infection. Since 2012, there have only been 3 confirmed cases of transmission while using Truvada. It costs between 50-60$ dollars per pill, but it is covered by most insurances, including Medicaid. Generic version has recently been FDA approved.  References: https:\/\/www.cdc.gov\/hiv\/pdf\/prep_gl_patient_factsheet_truvada_english.pdf ","author_name":"Emergency Medical Minute","author_url":"https:\/\/www.emergencymedicalminute.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/6198036\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/fa102a\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/18843778"}